1Harold L. Investigation and treatment of vertigo[ J ]. Practitioner, 1994,738(1535) : 126.
2Van Cauwenberge PB,De Moor SEG. Physiopathology of H3 - receptors and pharmacology of Betahistine [ J ]. Acta Otolaryngol (Stockh), 1997,526 (Suppl) :S43.
3Arrang JM, Garbarge M, Thanh Quach T, et al. Actions of betahistine at histamine receptors in the brain[J]. Eur J Pharm, 1985,111 (1) :73.
4Timmerman H. Histamine H3 ligands:just pharmacological tools or potential therapeutic agents[ J ]. J Med Chem, 1990,33 ( 1 ) : 4.
5Timmerman H. Histamine agonists and antagonists[J ]. Acta Otolaryngol(Stockh), 1991,479 (Suppl) : S5.
6Arrang JM, Devaux B, Chodldewicz JP, et al. H3 - receptors control histamine release in human brain [J ]. J Neurochem, 1988,51 ( 1 ) : 105.
7Schwartz JC, Arrang JM, Garbarg M, et al. A third histamine receptor type: characterisation, localisation and functions of the H3 - receptor[J ]. Agent Actions, 1990,30( 1 - 2) : 13.
8Serafin M, Khateb A, Vibert N, et al. Medial vestibular nucleus in the guinea- pig: histaminergic receptors. I. An in vitro study[J ]. Exp Brain res, 1993,93(2) :242.
9Laurikainen EA, Miller JM, Quirk WS, et al. Betahistine - induced vascular effects in the rat cochlea[ J ]. Am J Otol, 1993,14 (1) : 24.
10Pathy J, Menon G, Reynolds A, et al. Betahistine hydrochloride (Serc)in cerebrovascular disease: a placebo - controlled study [ J ]. Age Ageing, 1977,6(3) : 179.
